Genetics and the metabolic syndrome
- E. Fanning; D. O'Shea Genetics and the metabolic syndrome Clin Dermatol
Metabolic Syndrome
A period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome
- A. Garcia-Rios; P. Perez-Martinez; J. Delgado-Lista; C. M. Phillips; I. M. F. Gjelstad; J. W. Wright; B. Karlström; B. Kiéc-Wilk; A. M. J. van Hees; O. Helal; A. Polus; C. Defoort; U. Riserus; E. E. Blaak; J. A. Lovegrove; C. A. Drevon; H. M. Roche; J. Lo A period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome Journal of Nutrition
Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
- J. A. Elliott; J. V. Reynolds Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma Front Oncol
Visceral obesity, metabolic syndrome, insulin resistance and cancer
- S. L. Doyle; C. L. Donohoe; J. Lysaght; J. V. Reynolds Visceral obesity, metabolic syndrome, insulin resistance and cancer Proc Nutr Soc
Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma
- S. L. Doyle; A. M. Mongan; C. L. Donohoe; G. P. Pidgeon; M. Sherlock; J. V. Reynolds; J. Lysaght Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma Dis Esophagus
Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent
- J. A. Elliott; N. E. Donlon; P. Beddy; C. L. Donohoe; S. L. Doyle; S. King; N. Ravi; J. V. Reynolds Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent Dis Esophagus
A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome
- J. Delgado-Lista; P. Perez-Martinez; A. Garcia-Rios; C. M. Phillips; W. Hall; I. M. F. Gjelstad; D. Lairon; W. Saris; B. Kieć-Wilk; B. Karlström; C. A. Drevon; C. Defoort; E. E. Blaak; A. Dembinska-Kieć; U. Risérus; J. A. Lovegrove; H. M. Roche; J. Lopez- A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome Nutrition, Metabolism and Cardiovascular Diseases
Top single nucleotide polymorphisms affecting carbohydrate metabolism in metabolic syndrome: From the LIPGENE study
- J. Delgado-Lista; P. Perez-Martinez; S. Juan; A. Garcia-Rios; A. I. Perez-Caballero; J. A. Lovegrove; C. A. Drevon; C. Defoort; E. E. Blaak; A. Dembinska-Kieć; U. Riśrus; E. Herruzo-Gomez; A. Camargo; J. M. Ordovas; H. Roche; J. Lopez-Miranda Top single nucleotide polymorphisms affecting carbohydrate metabolism in metabolic syndrome: From the LIPGENE study Journal of Clinical Endocrinology and Metabolism
Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: The LIPGENE study
- C. Cruz-Teno; P. Pérez-Martínez; J. Delgado-Lista; E. M. Yubero-Serrano; A. García-Ríos; C. Marín; P. Gómez; Y. Jiménez-Gómez; A. Camargo; F. Rodríguez-Cantalejo; M. M. Malagón; F. Pérez-Jiménez; H. M. Roche; J. López-Miranda Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: The LIPGENE study Molecular Nutrition and Food Research
Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants
- P. J. Curtis; L. Berends; V. van der Velpen; A. Jennings; L. Haag; P. Chandra; C. D. Kay; E. B. Rimm; A. Cassidy Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants Clinical Nutrition